Suchergebnisse - "antibodies"

PubPharm (22.806)

51

Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination : A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults

enthalten in: Journal of medical virology | 2024

von Meng, H. | Wang, Y. | Zhai, Y. | +10

52

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery

enthalten in: Clinical and experimental immunology | 2024

von Ali, M. | Longet, S. | Neale, I. | +31

53

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation

enthalten in: Nature communications | 2024

von Park, S. | Choi, J. | Lee, Y. | +14

54

Autoimmunity in Syndromes of Orthostatic Intolerance : An Updated Review

enthalten in: Journal of personalized medicine | 2024

von Pena, C. | Moustafa, A. | Mohamed, A. | +1

55

A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2

enthalten in: Antiviral research | 2024

von Wang, W. | Wang, S. | Meng, X. | +6

56

Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge

enthalten in: Vaccine | 2024

von Hill-Batorski, L. | Bowen, R. | Bielefeldt-Ohmann, H. | +6

57

Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir) : a retrospective cohort study

enthalten in: BMC pharmacology & toxicology | 2024

von Yalan, Q. | Lingfang, H. | Xisong, L. | +3

58

Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years : an open-labeled, single-arm clinical trial

enthalten in: BMC infectious diseases | 2024

von Huang, T. | Hu, Q. | Zhou, X. | +10

59

Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study

enthalten in: BMC pharmacology & toxicology | 2024

von Yalan, Q. | Lingfang, H. | Xisong, L. | +3

60

Infliximab Concentrations in Participants with Moderate to Severe COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Balevic, S. | Dandachi, D. | Dixon, D. | +4